世界の大腸がんのスクリーニングと診断市場

Report Highlights

The global market for colorectal cancer screening and diagnostic testing services is estimated to increase from $40.0 billion in 2024 to reach $46.1 billion by 2029, at a compound annual growth rate (CAGR) of 2.9% from 2024 through 2029.

大腸がんのスクリーニングと診断検査サービスの世界市場は、2024年から2029年にかけて年平均成長率（CAGR）2.9%で拡大し、2024年の400億ドルから2029年には461億ドルに達すると予測されています。

The increasing incidence of colorectal cancer, rise in demand for non-invasive colorectal cancer screening, growing need for early cancer detection to lower treatment cost, advances in genomics and molecular diagnostics, and rising financial burden on healthcare are key factors driving the market’s growth. However, the limited sensitivity of non-invasive testing methods, sample collection challenges, and stringent regulations might hinder the market’s growth in the next five years.

大腸がんの発生率の増加、非侵襲的大腸がんスクリーニングの需要の増加、治療費の削減を目的とした早期がん検出の必要性の高まり、ゲノミクスと分子診断の進歩、医療に対する財政的負担の増加は、市場の成長を牽引する主な要因です。ただし、非侵襲的検査方法の感度の限界、サンプル収集の課題、厳格な規制により、今後 5 年間の市場の成長が妨げられる可能性があります。

Report Scope

This report summarizes the colorectal cancer screening and diagnostic testing service market, including a market snapshot and company profiles of leading product manufacturers/service providers. It provides a comprehensive market breakdown with in-depth information regarding each segment. The overview section of the report describes market trends and dynamics, including drivers, challenges, and opportunities. It provides information on emerging technologies and developments in the industry. The report also analyzes critical market players’ financials, product portfolios, and recent activities.

このレポートは、大腸がんのスクリーニングおよび診断検査サービス市場の概要をまとめたもので、市場のスナップショットや主要な製品メーカー/サービスプロバイダーの企業プロファイルが含まれています。各セグメントに関する詳細な情報を含む包括的な市場の内訳を提供します。レポートの概要セクションでは、推進要因、課題、機会など、市場の傾向と動向について説明します。業界の新興技術と開発に関する情報を提供します。レポートでは、重要な市場プレーヤーの財務、製品ポートフォリオ、最近の活動も分析します。

BCC Research analyzed and made projections of each market and its applications, along with forecasts for the next five years. The report also features profiles of leading product manufacturers/service providers in the colorectal cancer screening and diagnostic testing service industry, including Fujifilm Holdings Corporation, Olympus Corporation, Exact Sciences Corporation, Danaher Corporation, Guardant Health, New Horizon Health, and Quest Diagnostics.

BCC リサーチは、各市場とその用途を分析、予測し、今後 5 年間の見通しも示しました。レポートには、富士フイルムホールディングス株式会社、オリンパス株式会社、Exact Sciences Corporation、Danaher Corporation、Guardant Health、New Horizo​​n Health、Quest Diagnostics など、大腸がんスクリーニングおよび診断検査サービス業界の大手製品メーカー/サービスプロバイダーのプロフィールも掲載されています。

Report Includes

– 37 data tables and 71 additional tables

– Analyses of trends in the global market for colorectal cancer screening and diagnostics, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029

– Estimates and forecasts of the market size by type, end user and geographic region

– Discussion of emerging technologies and developments, and the macroeconomic factors affecting the market

– Coverage of stages, etiology, pathophysiology, and risk factors of colorectal cancer, and discussion on its diagnosis, regulatory framework and reimbursement scenarios

– Information on product pipeline, approvals, launches and expansions and funding and grants in the medical industry

– Review of patent data and other new developments

– Discussion of ESG challenges and practices of the industry

– Assessment of the competitive landscape, including the market shares of leading companies, their product portfolios and financial overviews

– Information on recent mergers and acquisitions, expansions, collaborations, investments, and divestments

– Company profiles of major players within the industry, including Fujifilm Holdings Corp., Olympus Corp., Exact Sciences Corp., Danaher Corp., and Guardant Health